IMVT vs VRTX: Which Stock is Better?
Side-by-side comparison of Immunovant Inc and Vertex Pharmaceuticals Inc in 2026
IMVT
Immunovant Inc
$26.55
VRTX
Vertex Pharmaceuticals Inc
$444.28
Key Metrics Comparison
| Metric | IMVT | VRTX | Winner |
|---|---|---|---|
| Market Cap | $5.11B | $111.93B | VRTX |
| P/E Ratio | N/A | 28.74 | VRTX |
| EPS (TTM) | $N/A | $15.31 | VRTX |
| Revenue Growth | 0.0% | 0.1% | VRTX |
| Gross Margin | 0.0% | 53.7% | VRTX |
Analyze IMVT
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMVT or VRTX a better investment?
Comparing IMVT and VRTX: Immunovant Inc has a market cap of $5.11B while Vertex Pharmaceuticals Inc has $111.93B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMVT and VRTX?
IMVT (Immunovant Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMVT or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMVT or VRTX?
VRTX has higher revenue growth at 0.1% vs 0.0% for IMVT.
Which company is more profitable: IMVT or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to 0.0% for IMVT.
Which is the larger company: IMVT or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $111.93B compared to $5.11B for IMVT.
Should I buy IMVT or VRTX in 2026?
Both IMVT and VRTX have investment merit. IMVT trades at $26.55 while VRTX trades at $444.28. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMVT and VRTX stock?
Key differences: Market Cap ($5.11B vs $111.93B), P/E Ratio (N/A vs 28.7x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 53.7%).